The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nuclear Medicine Radioisotopes Market Research Report 2025
Synopsis
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
The global Nuclear Medicine Radioisotopes market was valued at US$ 3457.9 million in 2023 and is anticipated to reach US$ 4486.1 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Radioisotopes.
Report Scope
The Nuclear Medicine Radioisotopes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine Radioisotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine Radioisotopes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Segment by Type
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Segment by Application
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nuclear Medicine Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nuclear Medicine Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
The global Nuclear Medicine Radioisotopes market was valued at US$ 3457.9 million in 2023 and is anticipated to reach US$ 4486.1 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Radioisotopes.
Report Scope
The Nuclear Medicine Radioisotopes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine Radioisotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine Radioisotopes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Segment by Type
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Segment by Application
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nuclear Medicine Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nuclear Medicine Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nuclear Medicine Radioisotopes Market Overview
1.1 Product Overview and Scope of Nuclear Medicine Radioisotopes
1.2 Nuclear Medicine Radioisotopes Segment by Type
1.2.1 Global Nuclear Medicine Radioisotopes Market Value Comparison by Type (2024-2030)
1.2.2 Thallium-201 (Tl-201)
1.2.3 Iodine (I-123)
1.2.4 Fluorine-18
1.2.5 Rubidium-82 (Rb-82)
1.2.6 Other
1.3 Nuclear Medicine Radioisotopes Segment by Application
1.3.1 Global Nuclear Medicine Radioisotopes Market Value by Application: (2024-2030)
1.3.2 Tumor
1.3.3 Heart Disease
1.3.4 Lymphoma
1.3.5 Thyroid Gland
1.3.6 Other
1.4 Global Nuclear Medicine Radioisotopes Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine Radioisotopes Revenue 2019-2030
1.4.2 Global Nuclear Medicine Radioisotopes Sales 2019-2030
1.4.3 Global Nuclear Medicine Radioisotopes Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nuclear Medicine Radioisotopes Market Competition by Manufacturers
2.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nuclear Medicine Radioisotopes Average Price by Manufacturers (2019-2024)
2.4 Global Nuclear Medicine Radioisotopes Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nuclear Medicine Radioisotopes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Medicine Radioisotopes, Product Type & Application
2.7 Nuclear Medicine Radioisotopes Market Competitive Situation and Trends
2.7.1 Nuclear Medicine Radioisotopes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nuclear Medicine Radioisotopes Players Market Share by Revenue
2.7.3 Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nuclear Medicine Radioisotopes Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine Radioisotopes Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nuclear Medicine Radioisotopes Global Nuclear Medicine Radioisotopes Sales by Region: 2019-2030
3.2.1 Global Nuclear Medicine Radioisotopes Sales by Region: 2019-2024
3.2.2 Global Nuclear Medicine Radioisotopes Sales by Region: 2025-2030
3.3 Global Nuclear Medicine Radioisotopes Global Nuclear Medicine Radioisotopes Revenue by Region: 2019-2030
3.3.1 Global Nuclear Medicine Radioisotopes Revenue by Region: 2019-2024
3.3.2 Global Nuclear Medicine Radioisotopes Revenue by Region: 2025-2030
3.4 North America Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.4.1 North America Nuclear Medicine Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nuclear Medicine Radioisotopes Sales by Country (2019-2030)
3.4.3 North America Nuclear Medicine Radioisotopes Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.5.1 Europe Nuclear Medicine Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nuclear Medicine Radioisotopes Sales by Country (2019-2030)
3.5.3 Europe Nuclear Medicine Radioisotopes Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.6.1 Asia Pacific Nuclear Medicine Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nuclear Medicine Radioisotopes Sales by Country (2019-2030)
3.6.3 Asia Pacific Nuclear Medicine Radioisotopes Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.7.1 Latin America Nuclear Medicine Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nuclear Medicine Radioisotopes Sales by Country (2019-2030)
3.7.3 Latin America Nuclear Medicine Radioisotopes Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Medicine Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nuclear Medicine Radioisotopes Sales by Type (2019-2030)
4.1.1 Global Nuclear Medicine Radioisotopes Sales by Type (2019-2024)
4.1.2 Global Nuclear Medicine Radioisotopes Sales by Type (2025-2030)
4.1.3 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2030)
4.2 Global Nuclear Medicine Radioisotopes Revenue by Type (2019-2030)
4.2.1 Global Nuclear Medicine Radioisotopes Revenue by Type (2019-2024)
4.2.2 Global Nuclear Medicine Radioisotopes Revenue by Type (2025-2030)
4.2.3 Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2019-2030)
4.3 Global Nuclear Medicine Radioisotopes Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nuclear Medicine Radioisotopes Sales by Application (2019-2030)
5.1.1 Global Nuclear Medicine Radioisotopes Sales by Application (2019-2024)
5.1.2 Global Nuclear Medicine Radioisotopes Sales by Application (2025-2030)
5.1.3 Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2030)
5.2 Global Nuclear Medicine Radioisotopes Revenue by Application (2019-2030)
5.2.1 Global Nuclear Medicine Radioisotopes Revenue by Application (2019-2024)
5.2.2 Global Nuclear Medicine Radioisotopes Revenue by Application (2025-2030)
5.2.3 Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2019-2030)
5.3 Global Nuclear Medicine Radioisotopes Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Agfa-Gevaert Group
6.1.1 Agfa-Gevaert Group Corporation Information
6.1.2 Agfa-Gevaert Group Description and Business Overview
6.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Portfolio
6.1.5 Agfa-Gevaert Group Recent Developments/Updates
6.2 Braco
6.2.1 Braco Corporation Information
6.2.2 Braco Description and Business Overview
6.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Braco Nuclear Medicine Radioisotopes Product Portfolio
6.2.5 Braco Recent Developments/Updates
6.3 Cardiarc
6.3.1 Cardiarc Corporation Information
6.3.2 Cardiarc Description and Business Overview
6.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cardiarc Nuclear Medicine Radioisotopes Product Portfolio
6.3.5 Cardiarc Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Corporation Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cardinal Health Nuclear Medicine Radioisotopes Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 CMR Naviscan (Gamma Medica Inc.)
6.5.1 CMR Naviscan (Gamma Medica Inc.) Corporation Information
6.5.2 CMR Naviscan (Gamma Medica Inc.) Description and Business Overview
6.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Portfolio
6.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Developments/Updates
6.6 Curium
6.6.1 Curium Corporation Information
6.6.2 Curium Description and Business Overview
6.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Curium Nuclear Medicine Radioisotopes Product Portfolio
6.6.5 Curium Recent Developments/Updates
6.7 Digirad
6.6.1 Digirad Corporation Information
6.6.2 Digirad Description and Business Overview
6.6.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Digirad Nuclear Medicine Radioisotopes Product Portfolio
6.7.5 Digirad Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GE Healthcare Nuclear Medicine Radioisotopes Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
6.9 Nordion (Canada)
6.9.1 Nordion (Canada) Corporation Information
6.9.2 Nordion (Canada) Description and Business Overview
6.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nordion (Canada) Nuclear Medicine Radioisotopes Product Portfolio
6.9.5 Nordion (Canada) Recent Developments/Updates
6.10 NTP Radioisotopes SOC
6.10.1 NTP Radioisotopes SOC Corporation Information
6.10.2 NTP Radioisotopes SOC Description and Business Overview
6.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.10.4 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Portfolio
6.10.5 NTP Radioisotopes SOC Recent Developments/Updates
6.11 Positron
6.11.1 Positron Corporation Information
6.11.2 Positron Nuclear Medicine Radioisotopes Description and Business Overview
6.11.3 Positron Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Positron Nuclear Medicine Radioisotopes Product Portfolio
6.11.5 Positron Recent Developments/Updates
6.12 Segami
6.12.1 Segami Corporation Information
6.12.2 Segami Nuclear Medicine Radioisotopes Description and Business Overview
6.12.3 Segami Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Segami Nuclear Medicine Radioisotopes Product Portfolio
6.12.5 Segami Recent Developments/Updates
6.13 Siemens Healthcare
6.13.1 Siemens Healthcare Corporation Information
6.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Description and Business Overview
6.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Siemens Healthcare Nuclear Medicine Radioisotopes Product Portfolio
6.13.5 Siemens Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Medicine Radioisotopes Industry Chain Analysis
7.2 Nuclear Medicine Radioisotopes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Medicine Radioisotopes Production Mode & Process
7.4 Nuclear Medicine Radioisotopes Sales and Marketing
7.4.1 Nuclear Medicine Radioisotopes Sales Channels
7.4.2 Nuclear Medicine Radioisotopes Distributors
7.5 Nuclear Medicine Radioisotopes Customers
8 Nuclear Medicine Radioisotopes Market Dynamics
8.1 Nuclear Medicine Radioisotopes Industry Trends
8.2 Nuclear Medicine Radioisotopes Market Drivers
8.3 Nuclear Medicine Radioisotopes Market Challenges
8.4 Nuclear Medicine Radioisotopes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
